John Lee

2021 - PhaseBio Pharmaceuticals

In 2021, John Lee earned a total compensation of $856.3K as Chief Medical Officer at PhaseBio Pharmaceuticals, a 6% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$192,003
Option Awards$207,414
Salary$442,900
Other$13,981
Total$856,299

Lee received $442.9K in salary, accounting for 52% of the total pay in 2021.

Lee also received $192K in non-equity incentive plan, $207.4K in option awards and $14K in other compensation.

Rankings

In 2021, John Lee's compensation ranked 9,275th out of 12,412 executives tracked by ExecPay. In other words, Lee earned more than 25.3% of executives.

ClassificationRankingPercentile
All
9,275
out of 12,412
25th
Division
Manufacturing
4,109
out of 5,498
25th
Major group
Chemicals And Allied Products
1,812
out of 2,374
24th
Industry group
Drugs
1,609
out of 2,095
23rd
Industry
Pharmaceutical Preparations
1,192
out of 1,542
23rd
Source: SEC filing on April 22, 2022.

Lee's colleagues

We found two more compensation records of executives who worked with John Lee at PhaseBio Pharmaceuticals in 2021.

2021

Jonathan Mow

PhaseBio Pharmaceuticals

Chief Executive Officer

2021

John Sharp

PhaseBio Pharmaceuticals

Chief Financial Officer

News

You may also like